Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets
Podcast: The Long Run with Luke TimmermanPublished On: Wed Sep 09 2026
Description: Mathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide molecules against hard targets of disease.
The note was deleted
The note was saved
Your message was sent